STERI-7 is a multi-purpose biocidal cleaner that also works as a high level disinfectant. It cleans practically any surface and any material, eradicating bacteria, spores and viruses.
What makes STERI-7 your ideal cleaning solution is that is also keeps treated areas contamination-free between cleaning cycles. This is because it goes on working once dried, something no other disinfectant is proven to do. The result is round the clock Biosecurity, with no window of opportunity for germs to re-establish themselves.
The success of STERI-7 over a wide range of environments and uses inspired the unique STERI-7 philosophy of Break, Treat, Prevent.
Break
STERI-7 hand washes and sanitisers helps BREAK the chain of infection.
Treat
Then, applying STERI-7 biocidal cleaner to the vulnerable spaces and surfaces will TREAT the pathogens at source.
Prevent
STERI-7 prevents any further re-infection.
The Benefits of STERI-7
Although most disinfectants are effective against pathogens they are only active while wet. As soon as the solution has dried it has no effect on new pathogens attacking the surface. Re-colonisation occurs within 20 minutes. Simply treat a surface with STERI-7 and within seconds Bacteria, Viruses and Spores on that surface will be killed.
But STERI-7 doesn’t stop there. Leave it to dry and a reactive barrier is created on the surface. STERI-7 Reactive Barrier Technology is available in our expanding product range from a simple hand spray to Hospital Grade high level cleaners.
What is STERI-7 Reactive Barrier Technology?
STERI-7 is a high-level, broad spectrum, one stage disinfectant cleaner. When applied to any surface from a floor to a wall or even a fabric, the biocide in STERI-7 kills Bacteria, Spores, Fungi, Viruses and Mould in seconds. But unlike any other disinfectant, STERI-7 incorporates a unique innovation called Reactive Barrier Technology.
Reactive Barrier Technology is a specialised micro emulsion which provides an optional sustained release system – this means that the Reactive Barrier can be switched on or off depending on the situation.
It’s simple, if you rinse STERI-7 after application you remove the Reactive Barrier, if you leave STERI-7 to dry you enable the Reactive Barrier Technology providing added biosecurity and protection between cleans.
Aqueos Disinfection Effectiveness
Aqueos blends a number of biocides with water on a polymer base to create a highly stable, broad spectrum disinfectant.
These biocides work synergistically together, each one enhancing the performance of the other, meaning they are present in very low concentrations and don’t have any hazard rating in the ready to use dilution, considerably reducing the risk of using them in comparison to more harmful alternatives.
Aqueos works at both a chemical and physical level meaning it acts quickly but also has long lasting efficacy which improves further with use. At the physical level, the disruption of the surface tension weakens the organisms as their hold on the treated surface is reduced. This surface disruption remains for a long period after the product has dried and has a cumulative effect over time.
Because the population is already physically weakened, it is then very vulnerable to attack from the combined chemical elements of the product. One further advantage of this method of killing micro-organisms is that they do not have the opportunity to develop resistance to the product.
All of the active ingredients within the Aqueos products are registered under the European Biocidal Product Regulations and are approved for use in Product Types 1 and 3 being Human Hygiene and Veterinary Hygiene respectively.
The disinfection solution used in the Aqueos range has been independently tested against a number of EN test standards, and has proven to be effective against bacteria, fungi and viruses. In most cases, Aqueos achieves a Log Factor 5 (99.999%) reduction: It has also been independently tested against Ringworm & Parvo Virus.
How does the Reactive Barrier Technology work?
Spray STERI-7 on a surface and leave to dry. Seconds later STERI-7 has killed 99.9999% of harmful bacteria, viruses, fungi, spores and moulds.
STERI-7 doesn’t stop there. When STERI-7 has dried, a barrier is created which reactivates in the presence of any moisture.
"For bacteria, viruses, fungi, spores and moulds to reproduce, they must contain moisture. However, the moisture they need, even though microscopic, is enough to activate STERI-7’s Reactive Barrier. Effectively the germs kill themselves. Pathogen suicide no less."
We wanted to prove STERI-7 Reactive Barrier Technology could be used to promote Biosecurity, so we asked an Industry recognised analytical laboratory to put STERI-7 and the Reactive Barrier Technology to the test.
Using an adapted version of protocol EN 13697 under ‘Dirty’ test conditions, STERI-7 was diluted with hard water. Hard water weakens a disinfectant’s efficacy. Spores, fungi and bacteria were chosen because these are some of the toughest pathogens to damage, never mind kill. If they could be killed under these conditions we knew STERI-7 could deal with almost anything.
The lab set their parameters. STERI-7 was sprayed onto stainless steel slides and left to dry. Once dried they were inoculated with selected bacteria, spores and fungi. After 1 minute contact time, the slides were swabbed with a dry sterile swab and analysed.
STERI-7 killed the lot.
5 minutes later the same stainless steel slides were inoculated, left for then 1 minute contact time and then swabbed with a new dry sterile swab.
Result? STERI-7 again killed the lot.
This procedure was repeated at 30 minutes, 60 minutes, and 72 hours later. Result? Guess what? STERI-7 once again killed the re-inoculated pathogens.
What does this mean for you?
As has been proven, STERI-7’s unrivalled Reactive Barrier Technology continues to be effective between cleans. And although it is extremely harmful to pathogens, it is not harmful to anything or anyone else.
All of STERI-7’s ingredients have worldwide approval so as well as being safe to use, non-toxic and non-corrosive.
STERI-7 - A genuine breakthrough in Biosecurity.
STERI-7 Test Data Summary:
|
Organism |
Laboratory |
Method |
Dilution |
Results (LOG) |
|---|---|---|---|---|
|
Coronavirus (FCoV) |
MSL laboratories |
EN 14476 Dilution Validation |
2% |
4.75 |
|
Coronavirus (FCoV) |
MSL laboratories |
EN 14476 Dilution Validation |
Neat |
4 |
|
Kio Herpes Virus |
Blutest |
EN 14475 |
4% |
4.17 |
|
Acinetobacter Baumannii |
Abbott Analytical |
BSEN 1276 |
2% |
6.52 |
|
Aspergillus fumigatus |
Abbott Analytical |
BSEN 1650 |
2% |
5.91 |
|
Aspergillus brasiliensis |
Abbott Analytical |
BSEN 13697 |
10% |
5.09 |
|
Aspergillus brasiliensis |
Abbott Analytical |
BSEN 1650 |
2% |
4.98 |
|
Aspergillus brasiliensis |
Irish Equine Centre |
EN 1656:2000 24 Hours |
2% |
6 |
|
Avian Flu Virus |
DEFRA/VLA LABORATORIES |
DEFRA Diseases of Poultry Test |
10% |
4.35 |
|
Bacillus |
Irish Equine Centre |
14 DAY IN-VIVO |
2% |
N/A |
|
Bacillus cereus |
Abbott Analytical |
BSEN 14347 |
2% |
6.47 |
|
Bacillus subtilis |
Abbott Analytical |
BSEN 14347 |
2% |
5.51 |
|
Bovine viral diarrhea virus |
BluScientific |
ASTM E1052 SAME DAY VIRUSES |
10% |
3.93 |
|
Bovine viral diarrhea virus |
BluScientific |
ASTM E1052 1 DAY VIRUSES |
10% |
4.04 |
|
Brochothrix thermosphacta |
Irish Equine Centre |
A semi-confluent lawn |
2% |
5 |
|
Burkholderia cenocepacia |
NIR Public Health Lab |
Prof J E Moore Study/Peer Review |
10% |
6 |
|
Burkholderia gladioli |
NIR Public Health Lab |
Prof J E Moore Study/Peer Review |
10% |
6 |
|
Burkholderia multivorans |
NIR Public Health Lab |
Prof J E Moore Study/Peer Reieww |
10% |
6 |
|
Campylobacter jejuni |
Abbott Analytical |
BSEN 1276 |
2% |
5.36 |
|
Campylobacter jejuni poultry isolate |
Irish Equine Centre |
A semi-confluent lawn |
2% |
5 |
|
Candida Albicans |
Abbott Analytical |
BSEN 13697 |
2% |
5.14 |
|
Clostridium Difficile |
Abbott Analytical |
BSEN 13704 |
2% |
4.4 |
|
Clostridium Difficile |
Abbott Analytical |
BSEN 13697 |
2% |
3.28 |
|
Clostridium difficile |
Abbott Analytical |
BSEN 13704 |
10% |
6.93 |
|
Clostridium perfringens |
Abbott Analytical |
BSEN 13704 |
10% |
5.69 |
|
Corynebacterium |
Irish Equine Centre |
14 DAY IN-VIVO |
2% |
5 |
|
E.coli |
Cheshire Scientific |
Hospital Ward Setting |
10% |
Not Present |
|
E.coli |
Irish Equine Centre |
14 DAY IN-VIVO |
2% |
5 |
|
EHV1 Herpes |
Animal Health Trust |
Fresh same day viruses |
2% |
6.3 |
|
EHV1 Herpes |
Animal Health Trust |
7 Day virus |
2% |
7 |
|
EHV1 Herpes |
Animal Health Trust |
14 Day virus |
2% |
7 |
|
EHV4 Herpes |
Animal Health Trust |
Fresh same day viruses |
2% |
4.2 |
|
EHV4 Herpes |
Animal Health Trust |
7 Day virus |
2% |
4.72 |
|
EHV4 Herpes |
Animal Health Trust |
14 Day virus |
2% |
3.67 |
|
EMRSA 15 |
NHS Freeman Hospital |
BSEN 13697 |
10% |
5.68 |
|
EMRSA 16 |
NHS Freeman Hospital |
BSEN 13697 |
10% |
5.04 |
|
Enterobacter faecalis |
Irish Equine Centre |
A semi-confluent lawn |
2% |
5 |
|
Enterobacter mundtii |
Irish Equine Centre |
A semi-confluent lawn |
2% |
5 |
|
Enterobacter phoeniculicola |
Irish Equine Centre |
A semi-confluent lawn |
2% |
5 |
|
Enterobacteria |
Abbott Analytical |
AIR CANADA |
10% |
N/A |
|
Enterococcus hirae |
NHS Research Lab |
BSEN 13727 |
10% |
6.28 |
|
Enterococcus hirae |
MGS |
BSEN 13727 |
10% |
6.5 |
|
Enterococcus hirae |
Abbott Analytical |
BSEN 1276 |
10% |
6.49 |
|
Enterococcus hirae |
Abbott Analytical |
BSEN 1276 LEMON |
10% |
6.71 |
|
Enterococcus hirae |
Abbott Analytical |
BESN 13697 LEMON |
10% |
6 |
|
Enterococcus hirae |
Abbott Analytical |
BSEN 1276 |
2% |
6.71 |
|
Enterococcus hirae |
Abbott Analytical |
BSEN 13697 |
1% |
6.44 |
|
Enterococcus hirae |
Abbott Analytical |
BSEN 14349 |
10% |
6.44 |
|
Enterococcus hirae |
Abbott Analytical |
BSEN 12054 |
Neat |
6.11 |
|
Enterococcus hirae |
Abbott Analytical |
BSEN 1276 (Hand Gel) |
Neat |
5.31 |
|
Enterococcus hirae |
Abbott Analytical |
BSEN 1276 (Hand Foam) |
Neat |
5.31 |
|
Enterococcus hirae |
Abbott Analytical |
BSEN 12054 ) |
Neat |
6.72 |
|
Escherichia coli |
Abbott Analytical |
BSEN 1276 |
2% |
6.62 |
|
Escherichia coli |
Abbott Analytical |
BSEN 1276 Aerosol Spray |
10% |
6.37 |
|
Escherichia coli |
Abbott Analytical |
BSEN 1276 LEMON |
2% |
6.52 |
|
Escherichia coli |
Abbott Analytical |
BESN 13697 LEMON |
2% |
6 |
|
Escherichia coli |
Abbott Analytical |
BSEN 1276 |
2% |
6.52 |
|
Escherichia coli |
Abbott Analytical |
BSEN 13697 |
2% |
5.4 |
|
Escherichia coli |
MGS |
BSEN 1276 |
2% |
6.5 |
|
Escherichia coli |
University Ottawa Canada |
QCT-1 QCT-2 QCT-2M 7 DAY |
10% |
6.39 |
|
Escherichia coli |
MGS |
7 DAY |
10% |
6 |
|
Escherichia coli |
Abbott Analytical |
BSEN 12054 |
Neat |
6.14 |
|
Escherichia coli |
Abbott Analytical |
BSEN 1500 |
Neat |
5.37 |
|
Escherichia coli |
Abbott Analytical |
BSEN 12791 (test for residual activity) |
Neat |
3.49 |
|
Escherichia coli |
Abbott Analytical |
BSEN 1276 (Hand Gel) |
Neat |
5.25 |
|
Escherichia coli |
Abbott Analytical |
BSEN 1276 (Hand Foam) |
Neat |
5.25 |
|
Escherichia coli |
Abbott Analytical |
BSEN 1499 Hand Wash |
Neat |
4.54 |
|
Escherichia coli |
Abbott Analytical |
BSEN 12791 3hrs RBT |
Neat |
4.5 |
|
Escherichia coli |
Abbott Analytical |
BSEN 12054 |
Neat |
6.7 |
|
Feline Calicivirus |
BluScientific |
EN 14476 |
2% |
4.83 |
|
Feline Coronavirus |
BluScientific |
ASTM E1052 1, 3 & 7 Day Viruses |
10% |
4.1 |
|
Feline Immunodeficiency |
BluScientific |
ASTM E1052 1, 3 & 7 Day Viruses |
10% |
3.7 |
|
Gram Neg Gram Pos Mould & Yeast |
Yorkshire Ambulance Service |
(Ambulance Decontamination ) |
2% |
N/A |
|
Hepatitis C |
BluScientific |
ASTM E1052 Viruses |
10% |
4.04 |
|
HIV |
BluScientific |
ASTM E1052 Viruses |
10% |
3.7 |
|
Influenza A virus H1N1 |
BluScientific |
ASTM E1052 Viruses |
10% |
4.96 |
|
Influenza A virus H1N1 |
BluScientific |
ASTM E1052 1 DAY Viruses |
10% |
3.79 |
|
Influenza A virus H1N1 |
BluScientific |
ASTM E1052 3 DAY Viruses |
10% |
3.84 |
|
Influenza A virus H1N1 |
BluScientific |
ASTM E1052 7 DAY Viruses |
10% |
3.59 |
|
Klebsiella pneumoniae NDM-1 |
Abbott Analytical |
BSEN 1276 |
2% |
6.44 |
|
Legionella pneumophila |
Abbott Analytical |
BSEN 13623 |
2% |
6.45 |
|
Listeria monocytogenes |
Abbott Analytical |
BSEN 13697 |
2% |
5.23 |
|
Listeria monocytogenes |
Abbott Analytical |
BSEN 13727 |
2% |
6.25 |
|
Listeria monocytogenes |
Irish Equine Centre |
A semi-confluent lawn |
2% |
5 |
|
M.R.S.A Equine clinical isolate |
Irish Equine Centre |
EN 1656:2000 24 Hours |
2% |
7 |
|
Mold & Yeast |
Cheshire Scientific |
Hospital Ward Setting |
10% |
Not present |
|
MRSA |
Abbott Analytical |
BSEN 13697 |
2% |
5.88 |
|
MRSA |
MGS |
BSEN 1276 |
2% |
6.4 |
|
MRSA |
MGS |
BSEN 13697 |
2% |
6.7 |
|
MRSA |
Abbott Analytical |
BSEN 13697 Wipes Immediate |
10% |
6 |
|
MRSA |
Abbott Analytical |
BSEN 13697 Wipes 1 DAY |
10% |
4 |
|
MRSA |
Abbott Analytical |
BSEN 13697 Wipes 2 DAY |
10% |
4 |
|
MRSA |
University Ottawa Canada |
QCT-1 QCT-2 QCT-2M 7 DAY |
10% |
6.79 |
|
MRSA |
Abbott Analytical |
BSEN 13727 |
2% |
6.25 |
|
MRSA FRANCE 95035 |
NHS Freeman Hospital |
BSEN 13697 |
10% |
5.12 |
|
MRSA NCTC 11939 |
NHS Freeman Hospital |
BSEN 13697 |
10% |
5.48 |
|
Mycobacterium fortuitium |
Abbott Analytical |
BSEN 14204 |
2% |
6.82 |